Navigation Links
SI-BONE, Inc. annuncia la pubblicazione dei dati sulla sicurezza della sorveglianza post-commercializzazione per i primi 5.319 pazienti trattati con il sistema di impianto iFuse Implant System
Date:6/5/2013

SAN JOSE, California, 5 giugno 2013 /PRNewswire/ -- SI-BONE, Inc. (San Jose, California), una società di dispositivi medicali pioniera nell'uso di dispositivi chirurgici a ridotta invasività (MIS) per la fusione dell'articolazione (SI) sacriliaca, ha annunciato oggi la pubblicazione dei dati sulla sicurezza della sorveglianza post-commercializzazione di iFuse Implant System's® per i primi 5.319 pazienti trattati.  Lo studio dal titolo: Analysis of the postmarket complaints database for the iFuse SI Joint Fusion System: a minimally invasive treatment for degenerative sacroiliitis and sacroiliac joint disruption, è stato pubblicato in Medical Devices: Evidence and Research il 28 maggio 2013.  Lo studio era mirato a fornire un'analisi delle lamentele sulla sorveglianza post-commercializzazione tramite la valutazione del database delle lamentele post-commercializzazione di SI-BONE .  L'analisi, che copre un periodo di 4 anni, dall'aprile 2009 al gennaio 2013 e comprende 5.319 pazienti, ha rivelato un tasso di lamentele complessivo post-commercializzazione del 3,8% che comprende un tasso totale di revisione dell'1,8% e un tasso di revisione tardiva postoperatoria dello 0,6%.  Le revisioni nel periodo postoperatorio tardivo sono state eseguite per trattare la ricorrenza della sintomatologia o per dolore persistente di eziologia non determinata in media a 279 giorni dopo l'operazione.1  Questi tassi sono coerenti con serie di casi pubblicati in precedenza di iFuse Implant System che segnalavano a 1-2 anni tassi di revisione successivi al trattamento dall'8% allo 0%.2,3    "Siamo estremamente orgoglioso della sicurezza e dell'efficacia clinica dimostrata dai chirurghi con la procedura the iFuse.  Il nostro obiettivo centrale come società è la sicurezza dei pazienti e un'efficacia della pr
'/>"/>

SOURCE SI-BONE, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SI-BONE, Inc. Announces Spring Society Meeting Attendance
2. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
3. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
4. Nonin Medical annuncia lo spostamento del Centro Assistenza Clienti dalla Svezia ai Paesi Bassi
5. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
6. Astute Medical, Inc. patrocinerà il simposio informativo presso il meeting sulla nefrologia in terapia intensiva
7. Lo screening trial sul cancro al seno conclude che lutilizzo della mammografia 3D in combinazione con un esame del seno 2D rileva un numero di tumori significativamente maggiore rispetto al solo esame del seno 2D
8. La nuova tecnologia Elekta per la radioterapia oncologica ridefinirà il futuro della lotta contro i tumori
9. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
10. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
11. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Sanomedics International Holdings, Inc. (OTCQB: SIMH) ... Research & Data Services, demand for thermometers is expected ... 2018, as demand for more accurate digital thermometers continues.  ... world,s largest market for thermometers, and one of the ... International Holdings, Inc. Sanomedics International Holdings designs, ...
(Date:10/22/2014)... NORWALK, Conn. , Oct. 22, 2014  Recently ... (GERD) have bolstered the already substantial database of evidence. ... and adoption of Stretta therapy for sufferers ... of clinical evidence supporting Stretta therapy as ... coverage policies that make Stretta therapy available to nearly ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional medical ... Toronto -based 3D visualization leader ... of Neurological Surgeons Annual Meeting that they have ... brain surgery. The collaboration is the first of ... to improve patient outcomes. NICO,s BrainPath® interventional access ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... ... ... - Spasticity Affects a Significant Number of Post-Stroke ... , , ...
... Robbins & Myers, Inc. (NYSE: RBN ) announced today that its Board of Directors approved a regular cash dividend payment of $0.0425 per share. , ... , , ... ... The dividend is payable on May 7, 2010 to shareholders of record as of ...
Cached Medicine Technology:First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 3First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 4First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 5First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 6First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 7First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 8First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 9
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... part of conventional in vitro fertilization (IVF) -- the incubation ... place in a device inside the vagina, new research suggests. ... the device, called an INVOcell, might sharply cut costs for ... the technology more accessible to those who don,t live near ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 With a ... Gov. Charlie Crist made a brief fundraising stop at ... on Thursday. , Fresh from a debate last night ... take the stage for the first seven minutes because ... former governor described the incident in one word: "weird." ...
(Date:10/20/2014)... T.E.N., a technology and information ... that William H. Murray, renowned author and industry ... Leadership Award winner. Presented annually, the ISE® Luminary ... leader and industry practitioner for his or her ... information security industry. , Formerly with IBM, Murray ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... disease is now reported to have spread in about 26 ... the disease is not fatal it weakens the immune system ... reported in Tasmania. Maharashtra state health minister Vimal Mundada said ... could be sensitized by this new disease and take necessary ...
... past two months while seven new HIV positive cases were identified ... alone, seven new HIV positive cases were identified in the district ... Chief Medical Superintendent Rajni Kant Gupta said., ,With this, the ... 30 of the infected were between 20 and 35 years, he ...
... up the lives of thousands of cancer patients, with hope ... gut.// Initial examinations of the drug have left a clue ... ,This drug called Sutent, nicknamed as the ... the cells to proliferate rapidly, as is the case in ...
... offered reduced price in fertility treatment if they donate eggs ... given permission for a scheme for ‘egg sharing' so as ... the women who agree for this scheme and pass on ... the cost of IVF treatment by almost half. ...
... Fatty acids found in oily fish won’t only make you ... fatty acids found in fish oil will help keep the ... of exercise.// , ,Professor Peter Howe, from the University of ... on 68 overweight-to-obese adults at risk of coronary disease and ...
... drew many activists who held a demonstration in Burlington after ... stance in support of the practice.// , The rally ... group kicked off World Breastfeeding Week. ,Activists marched ... that say breastfeeding is not just a private bond between ...
Cached Medicine News:Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 3Health News:Fatty Acids In Fish Oil Helps Fight Obesity 2Health News:Wide Support for Breast feeding 2
ROB-NEL Catheters (100% Latex-Free)...
100% Silicone Foley Catheter Kits 2-Way...
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 2-Way (Pediatric)...
Medicine Products: